Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway
Aims: Interleukin (IL)-1β is one of the major pathogenic regulators during the pathological development of intervertebral disc degeneration (IDD). However, effective treatment options for IDD are limited. Suramin is used to treat African sleeping sickness. This study aimed to investigate the pharmac...
Main Authors: | Zi-Miao Liu, Cheng-Chang Lu, Po-Chih Shen, Shih-Hsiang Chou, Chia-Lung Shih, Jian-Chih Chen, Yin Chun Tien |
---|---|
Format: | Article |
Language: | English |
Published: |
The British Editorial Society of Bone & Joint Surgery
2021-08-01
|
Series: | Bone & Joint Research |
Subjects: | |
Online Access: | https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.108.BJR-2020-0041.R3 |
Similar Items
-
ACAN Gene VNTR Polymorphism and Intervertebral Disc Degeneration in a Turkish Population
by: Tuba Öz, et al.
Published: (2020-09-01) -
Metformin inhibits the apoptosis of intervertebral disc tissue cells in rabbit model with lumbar intervertebral disc degeneration
by: DONG Junli, CAI Shaokang, YAN Lei, CAI Yi
Published: (2023-01-01) -
Role of Caspase Family in Intervertebral Disc Degeneration and Its Therapeutic Prospects
by: Lei Li, et al.
Published: (2022-08-01) -
Intervertebral disc cell fate during aging and degeneration: apoptosis, senescence, and autophagy
by: Takashi Yurube, M.D., Ph.D., et al.
Published: (2023-06-01) -
Application of stem cells in the repair of intervertebral disc degeneration
by: Wentao Zhang, et al.
Published: (2022-02-01)